Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,835,128
+$551,130 QoQ
Shares Held
1,530
+9.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#2,565
of 4,605 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STANCE CAPITAL LLC holds $17,488,887 across 8 Drug Manufacturers - General names. LLY ranks #6 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
13,480 | $4,881,377 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
36,089 | $4,559,483 | |
| 3 | ABBV |
AbbVie Inc.
|
7,664 | $1,928,568 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,779 | $1,899,101 | |
| 5 | PFE |
Pfizer Inc
|
78,762 | $1,896,588 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
1,530 | $1,835,128 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,240 | $474,788 | |
| 8 | NVO |
Novo Nordisk A S
|
289 | $13,854 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,835,128 | 1,530 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,283,998 | 1,396 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,479,834 | 1,377 | Shares | Defined | 2026-03-17 | |
| 2025-06-30 | $1,236,334 | 1,586 | Shares | Defined | 2025-08-22 | |
| 2025-03-31 | $1,250,427 | 1,514 | Shares | Defined | 2025-05-16 | |
| 2024-12-31 | $250,128 | 324 | Shares | Defined | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||